From the Division of Plastic Surgery, Department of Surgery, University of California, San Francisco, San Francisco, CA.
Division of Plastic Surgery, Department of Surgery, Ucahn School of Medicine at Mount Sinai.
Ann Plast Surg. 2021 May 1;86(5):601-606. doi: 10.1097/SAP.0000000000002576.
In the last decade, a number of studies have demonstrated the utility of indocyanine green (ICG) angiography in predicting mastectomy skin flap necrosis for immediate breast reconstruction. However, data are limited to investigate this technique for autologous breast reconstruction. Although it may have the potential to improve free flap outcomes, there has not been a large multicenter study to date that specifically addresses this application.
A thorough literature review based on Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines was conducted. All studies that examined the use of intraoperative ICG angiography or SPY to assess perfusion of abdominally based free flaps for breast reconstruction from January 1, 2000, to January 1, 2020, were included. Free flap postoperative complications including total flap loss, partial flap loss, and fat necrosis were extracted from selected studies.
Nine relevant articles were identified, which included 355 patients and 824 free flaps. A total of 472 free flaps underwent clinical assessment of perfusion intraoperatively, whereas 352 free flaps were assessed with ICG angiography. Follow-up was from 3 months to 1 year. The use of ICG angiography was associated with a statistically significant decrease in flap fat necrosis in the follow-up period (odds ratio = 0.31, P = 0.02). There was no statistically significant difference for total or partial flap loss.
From this systematic review, it can be concluded that ICG angiography may be an effective and efficient way to reduce fat necrosis in free flap breast reconstruction and may be a more sensitive predictor of flap perfusion than clinical assessment alone. Future prospective studies are required to further determine whether ICG angiography may be superior to clinical assessment in predicting free flap outcomes.
在过去的十年中,许多研究已经证明了吲哚菁绿(ICG)血管造影术在预测即刻乳房再造乳房皮瓣坏死方面的效用。然而,数据仅限于研究这种技术在自体乳房再造中的应用。尽管它可能有潜力改善游离皮瓣的结果,但迄今为止,还没有一项大型多中心研究专门针对这种应用。
根据系统评价和荟萃分析的首选报告项目进行了全面的文献复习。所有研究均检查了术中 ICG 血管造影或 SPY 用于评估从 2000 年 1 月 1 日至 2020 年 1 月 1 日接受腹部游离皮瓣乳房再造的皮瓣灌注的使用情况。从选定的研究中提取游离皮瓣术后并发症,包括总皮瓣坏死、部分皮瓣坏死和脂肪坏死。
确定了 9 篇相关文章,其中包括 355 名患者和 824 个游离皮瓣。共有 472 个游离皮瓣在术中进行了灌注的临床评估,而 352 个游离皮瓣接受了 ICG 血管造影检查。随访时间为 3 个月至 1 年。在随访期间,使用 ICG 血管造影与皮瓣脂肪坏死发生率降低呈统计学显著相关(比值比=0.31,P=0.02)。总皮瓣或部分皮瓣坏死无统计学差异。
从这项系统评价中可以得出结论,ICG 血管造影术可能是减少游离皮瓣乳房再造中脂肪坏死的有效且高效的方法,并且可能比单独的临床评估更能敏感地预测皮瓣灌注。需要进一步进行前瞻性研究以确定 ICG 血管造影术是否可能优于临床评估来预测游离皮瓣结果。